A HUGE @DermTalks THANK YOU to @dr_shreya_derm for walking us through this rapidly expanding area of medicine! ☺️

@dr_shreya_derm kicks off her talk with a lesson on the history of web-based research. Significant changes between now and 1995, but she notes largest changes with the dawn of the smart phone era in 2010, and in 2020 with the onset of the Pandemic

Unfortunately, this talk had to be postponed to a later date. Stay tuned for updates!

Why was 6 afraid of 7❓ Because 7 didn’t really understand HHV-8 😉 Don’t be like 7… Join us Monday September 2nd as Dr. Dirk Dittmer of @UNC_Lineberger gives his perspective on Kaposi Sarcoma 🔴 Register Here ⬇️⬇️⬇️ zoom.us/WEBINAR/REGISTER/WN_…

While the Olympic Games have all eyes watching the TOP of the podium, @DermTalks is focused on the TOP as well... that is TOPICAL Immunotherapy for Skin Cancer‼️ Join us Monday August 5th as @CaImmunoprevent talks us through skin cancer immunoprevention 🤩

Register Here⬇️⬇️ zoom.us/WEBINAR/REGISTER/WN_…

Un grand @DermTalks merci au Dr. Chanal pour nous avoir enseigné aujourd’hui!

Starting shortly!!!

As many of you may know it’s ❗️VITILIGO AWARENESS MONTH❗️ We’re joined today by Dr. Iltefat Hamzavi of Henry Ford Health and @ErikaPage (@LivingDappled) who will update us on advancements in this area of study and provide insight into the patient experience respectively

A BIG @DermTalks THANK YOU to Dr. Carol Feghali-Bostwick and to Dr. Karen Kemper for their informative talk and for the staunch reminder to prioritize the patient experience when providing care 🫂✨

There are lots of opportunities to support patients: @scleroderma -Annual National Education Meeting -Patient and caregiver support groups -Medical Professional Education and Meeting -Scleroderma Research Grant program -ADVOCACY scleroderma.org

Dr. Kemper emphasizes that you shouldn't have to have deformities to be believed you have something going on with you While there may be many phenotypical similarities between patients, the outward manifestation of disease (or lack thereof) can affect the care patients receive

3 things to consider as a health care provider treating systemic sclerosis/scleroderma: 1) prioritize decreasing time between symptom onset and diagnosis 2) listen to the patient when they say “something isn’t right” 3) recognize the heterogeneity of the patient population

Kicking off Scleroderma awareness month with a BANG❗️ Dr. Carol Feghali-Botswick starts out the talk with some background about this disease. We’re looking at a 10-year mortality rate of ~50%